AstraZeneca heralds new chapter as Alexion acquisition completed

AstraZeneca heralds new chapter as Alexion acquisition completed

Source: 
Biopharma Reporter
snippet: 

AstraZeneca has completed the acquisition of Alexion Pharmaceuticals, Inc., marking its entry into medicines for rare diseases.